Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
about
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of actionDysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review)Viral infection, inflammation and schizophreniaAntioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Meta-analysis of oxidative stress in schizophrenia.Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorderOxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognitionOxidative stress in schizophrenia: an integrated approach.N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.Analysis of manganese superoxide dismutase (MnSOD: Ala-9Val) and glutathione peroxidase (GSH-Px: Pro 197 Leu) gene polymorphisms in mood disorders.Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersThe link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress.Upstream Pathways Controlling Mitochondrial Function in Major Psychosis: A Focus on Bipolar DisorderOxidative stress and psychological disorders.Evaluation of Oxidative Stress in Bipolar Disorder in terms of Total Oxidant Status, Total Antioxidant Status, and Oxidative Stress Index.Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.Insulin dysfunction and allostatic load in bipolar disorder.Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders.Staging and neuroprogression in bipolar disorder.Novel biomarkers for bipolar disorder.Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.Lipid peroxidation in psychiatric illness: overview of clinical evidenceBiomarkers and staging of bipolar disorder: a systematic review.Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis.Possible biomarkers modulating haloperidol efficacy and/or tolerability.Update on bipolar disorder biomarker candidates.A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC.Inflammation, neurotrophism and oxidative stress and childhood psychopathology in a large community sample.Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders.The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence.Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatryAntipsychotic-like effect of minocycline in a rat model.N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats.Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia.Omega-3 fatty acids alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration.Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels.(1)H-MRS of hippocampus in patients after first manic episode.
P2860
Q24615952-5F581910-A93E-4BBB-BC62-C7BB6C545F1AQ28066841-86D6867B-B4B8-46DF-97E9-13A40C586F12Q30440507-128393EE-BD67-48C3-8841-EA7ED66026B1Q33350202-05111030-910A-4B42-9354-591ABF6B31DEQ33601360-68D3E774-46CA-4D31-ADDE-295658D734B8Q33904833-1D51B0EB-A404-4ABE-8BD5-A5A4AE9E0D50Q34228522-BED69FC7-5BBA-46E0-866C-04795F65A33EQ34268156-D9F0F5E9-FA98-4227-BD4D-DA595D64F237Q34270701-F0757F3E-749C-4C19-B4A2-5D28FAB84794Q34494844-D57502C3-1DCA-4417-AFE5-C081AF2E5745Q34543171-DB72A1D8-210F-4BB6-8346-38E2C17B241CQ35099770-B333A770-B43D-4378-8E6F-40C5A2D6A301Q35157958-5CF14B48-C8EA-4C39-823C-970A5DD05A65Q35246024-4677F03D-7497-47EC-B1D3-AFAF869CCBF1Q35853134-FD05022E-8E13-44F5-A522-5F2DF757A969Q37123412-26866C20-87A2-43F3-984E-939FE3A5C042Q37661360-610392A7-B568-483E-ABFE-0CDC8316C515Q37735572-F36C6B76-60AB-4F70-9A92-D7D1D3401B93Q37825989-4C868235-B8AE-4AF3-BCFF-6E72028ED6E0Q37896630-866E3161-E576-4F58-B0F1-141D4E040BA1Q38019745-8E9EF613-9E0E-4E03-94D3-660AAEE67414Q38054585-11910F86-2370-4591-B272-DD8714D607E4Q38093255-64AD44DF-16F8-4E2F-97CC-42003F3E685AQ38125218-940601F6-8B68-49A2-A09B-A8AD69B3B98DQ38215504-090610CE-16E2-47AC-A562-0D9C72B1E95BQ38414455-2B40B4C8-BDB3-4723-8A84-EFB8CB43D139Q38727291-125E40A8-670D-4184-A7A8-002D41CBED4EQ38792346-4E39A4BA-537F-4A4E-935D-A9150CF147EBQ38803583-038DAB37-A254-4F53-9DA6-70E4106417A2Q39633244-E964FF50-91C4-498B-AF40-9D23000328F2Q40771842-36AC6F94-3BB3-4B21-8692-5966229CC045Q41143093-3681DDA0-5E94-4AF0-A434-24387539C2F5Q41286620-DC95CB15-64D0-408A-A9A5-43C849512BBFQ41687474-930919A5-4081-40E6-A6B4-A03A54374BA8Q43015622-61C6C610-F5ED-4B28-80C9-69AA88C1FF69Q46017960-A5B4E2C9-CDA9-48EF-8AE4-184491A1E8A7Q47713512-335AB768-AF54-4F1F-BE38-D1A2304D8EB3Q47813961-C3243025-A101-494B-8EAC-8891CD266F7AQ48363538-BEB3F5B2-557C-4C02-ACB8-E2B8D076771AQ49106947-EEC78E25-E184-4DFC-B4FD-E704F59BBDD8
P2860
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Elevated serum superoxide dism ...... disorder and in schizophrenia.
@en
Elevated serum superoxide dism ...... disorder and in schizophrenia.
@nl
type
label
Elevated serum superoxide dism ...... disorder and in schizophrenia.
@en
Elevated serum superoxide dism ...... disorder and in schizophrenia.
@nl
prefLabel
Elevated serum superoxide dism ...... disorder and in schizophrenia.
@en
Elevated serum superoxide dism ...... disorder and in schizophrenia.
@nl
P2093
P50
P1476
Elevated serum superoxide dism ...... disorder and in schizophrenia.
@en
P2093
Fabiano Alves Gomes
Keila Mendes Ceresér
Mirian Salvador
P304
P356
10.1016/J.PNPBP.2008.07.001
P50
P577
2008-07-06T00:00:00Z